$1.55
0.021.31%
At Close: -
$1.58
0.031.94%
After Hours: Aug 19, 4:06 PM EDT
15 minutes delayed
Reneo Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Reneo Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.16 | $-0.10 | -60.0 % |
Mar 2024 | 2024-05-07 | $-0.25 | $-0.29 | 13.8 % |
Dec 2023 | 2024-03-28 | $-0.70 | $-0.62 | -12.9 % |
Sep 2023 | 2023-11-13 | $-0.57 | $-0.57 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Reneo Pharmaceuticals (RPHM) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.16, which missed the estimate of $-0.10.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.